Literature DB >> 11992649

Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat.

Salvatore Cuzzocrea1, Emanuela Mazzon, Lidia Sautebin, Laura Dugo, Ivana Serraino, Angela De Sarro, Achille P Caputi.   

Abstract

In the present study, we evaluated the effect of Celecoxib, a selective COX-2 inhibitor, in an acute model of lung injury induced by carrageenan administration in the rats. Injection of carrageenan into the pleural cavity of rats elicited an acute inflammatory response characterized by: fluid accumulation in the pleural cavity which contained a large number of polymorphonuclear neutrophils (PMNs) as well as an infiltration of PMNs in lung tissues and subsequent lipid peroxidation, and increased production of prostaglandin E(2) (PGE(2)), tumor necrosis factor alpha (TNFalpha), and interleukin-1beta. All parameters of inflammation were attenuated by Celecoxib. Furthermore, carrageenan induced an upregulation of the adhesion molecules ICAM-1 and P-selectin, as well as nitrotyrosine and poly(ADP-ribose) synthetase (PARS) as determined by immunohistochemical analysis of lung tissues. The degree of staining for the ICAM-1, P-selectin, nitrotyrosine and PARS was reduced by Celecoxib. These results clearly confirmed that COX-2 plays a critical role in the development of the inflammatory response by altering key components of the inflammatory cascade. Therefore, selective inhibitor of COX-2 such as Celecoxib, offers a therapeutic approach for the management of various inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992649     DOI: 10.1016/s0006-2952(01)00908-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  17 in total

1.  Albumin microspheres as carriers for the antiarthritic drug celecoxib.

Authors:  Hetal Thakkar; Rakesh Kumar Sharma; Anil Kumar Mishra; Krishna Chuttani; Rayasa Ramchandra Murthy
Journal:  AAPS PharmSciTech       Date:  2005-09-20       Impact factor: 3.246

2.  Inhibition of glycogen synthase kinase-3beta attenuates the development of carrageenan-induced lung injury in mice.

Authors:  S Cuzzocrea; C Crisafulli; E Mazzon; E Esposito; C Muià; M Abdelrahman; R Di Paola; C Thiemermann
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

3.  Protective effect of magnolol on lipopolysaccharide-induced acute lung injury in mice.

Authors:  Yun Feng Ni; Tao Jiang; Qing Shu Cheng; Zhong Ping Gu; Yi Fang Zhu; Zhi Pei Zhang; Jian Wang; Xiao Long Yan; Wu Ping Wang; Chang Kang Ke; Yong Han; Xiao Fei Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

4.  Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy.

Authors:  Matteo Ceccarelli; Daniele Bani; Lorenzo Cinci; Silvia Nistri; Caterina Uliva; Elena Ragazzo; Alfredo Vannacci; Marco Manoni; Anna Maria Gori; Rosanna Abbate; Gian Franco Gensini; Emanuela Masini
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.310

5.  Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression.

Authors:  Hassan Ali; Ashrafullah Khan; Jawad Ali; Hadayat Ullah; Adnan Khan; Hussain Ali; Nadeem Irshad; Salman Khan
Journal:  BMC Pharmacol Toxicol       Date:  2020-11-25       Impact factor: 2.483

6.  Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation.

Authors:  Na Young Yi; Donna R Newman; Huiying Zhang; Helena Morales Johansson; Philip L Sannes
Journal:  Exp Lung Res       Date:  2015       Impact factor: 2.459

7.  Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement.

Authors:  Takahisa Murata; Kosuke Aritake; Yoshiki Tsubosaka; Toshihiko Maruyama; Takayuki Nakagawa; Masatoshi Hori; Hiroyuki Hirai; Masataka Nakamura; Shuh Narumiya; Yoshihiro Urade; Hiroshi Ozaki
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-11       Impact factor: 11.205

8.  Involvement of bradykinin, cytokines, sympathetic amines and prostaglandins in formalin-induced orofacial nociception in rats.

Authors:  Juliana G Chichorro; Berenice B Lorenzetti; Aleksander R Zampronio
Journal:  Br J Pharmacol       Date:  2004-03-08       Impact factor: 8.739

9.  Fabrication and Evaluation of Celecoxib Oral Oleogel to Reduce the Inflammation of Ulcerative Colitis.

Authors:  Nermin M Sheta; Sylvia A Boshra
Journal:  AAPS PharmSciTech       Date:  2021-06-15       Impact factor: 3.246

10.  Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation.

Authors:  Concetta Crisafulli; Emanuela Mazzon; Irene Paterniti; Maria Galuppo; Placido Bramanti; Salvatore Cuzzocrea
Journal:  Respir Res       Date:  2010-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.